Caffeine and Cataract After Pars Plana Vitrectomy - Trial NCT06358664
Access comprehensive clinical trial information for NCT06358664 through Pure Global AI's free database. This phase not specified trial is sponsored by Vienna Institute for Research in Ocular Surgery and is currently Recruiting. The study focuses on Cataract. Target enrollment is 74 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Vienna Institute for Research in Ocular Surgery
Timeline & Enrollment
N/A
Apr 01, 2024
Apr 01, 2026
Primary Outcome
Significant cataract formation at year 1
Summary
Assessment of cataract development in patients with regular caffeine consumption and those
 without caffeine consumption after pars plana vitrectomy.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06358664
Non-Device Trial